GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Short-Term Debt

Oventus Medical (ASX:OVN) Short-Term Debt : A$0.20 Mil (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Short-Term Debt?

Oventus Medical's Short-Term Debt for the quarter that ended in Dec. 2021 was A$0.20 Mil.

Oventus Medical's quarterly Short-Term Debt declined from Dec. 2020 (A$0.21 Mil) to Jun. 2021 (A$0.00 Mil) but then increased from Jun. 2021 (A$0.00 Mil) to Dec. 2021 (A$0.20 Mil).


Oventus Medical Short-Term Debt Historical Data

The historical data trend for Oventus Medical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Short-Term Debt Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
Short-Term Debt
- - - - -

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.11 - 0.21 - 0.20

Oventus Medical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Oventus Medical Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines